UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data

Scientific reports, 2021-01, Vol.11 (1), p.607-16, Article 607

2021

Volltextzugriff (PDF)

Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan

Multiple sclerosis journal - experimental, translational and clinical, 2017-12, Vol.3 (4), p.2055217317748972-2055217317748972

2017

Volltextzugriff (PDF)

Association between peripheral plasmablasts and postoperative exacerbation in patients with thymoma‐associated myasthenia gravis

Clinical & experimental neuroimmunology, 2019-05, Vol.10 (2), p.110-117

2019

Volltextzugriff (PDF)

Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial

Lancet neurology, 2020-04, Vol.19 (4), p.298-306

2020

Volltextzugriff (PDF)

Cognition with magnetic resonance imaging findings and social activities in patients with multiple sclerosis in a Japanese cohort

Clinical & experimental neuroimmunology, 2019-02, Vol.10 (1), p.41-48

2019

Volltextzugriff (PDF)

Diagnostic criteria to patients with multiple sclerosis and clinically isolated syndrome

Nihon rinshō, 2015-09, Vol.73 Suppl 7, p.173

Fukaura, Hikoaki

2015

Volltextzugriff (PDF)

Disease modifying therapies in multiple sclerosis

Nihon rinshō, 2014-11, Vol.72 (11), p.2015

Fukaura, Hikoaki

2014

Volltextzugriff (PDF)

Detection of Active Plaques in Multiple Sclerosis using Susceptibility-weighted Imaging: Comparison with Gadolinium-enhanced MR Imaging

Magnetic Resonance in Medical Sciences, 2011, Vol.10(3), pp.185-192

2011

Volltextzugriff (PDF)

Association of cognitive impairment with magnetic resonance imaging findings and social activities in patients with multiple sclerosis

Clinical & experimental neuroimmunology, 2014-10, Vol.5 (3), p.328-335

2014

Volltextzugriff (PDF)

Ibudilast, a nonselective phosphodiesterase inhibitor, regulates Th1/Th2 balance and NKT cell subset in multiple sclerosis

Multiple sclerosis, 2004-10, Vol.10 (5), p.494-498

2004

Volltextzugriff (PDF)

Present status of Japanese neurologists from the questionnaire survey - to support women doctor's career advancement

Rinsho shinkeigaku = Clinical neurology, 2013, Vol.53 (11), p.1354-1357

Fukaura, Hikoaki

2013

Volltextzugriff (PDF)

Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood–brain barrier breakdown and peripheral plasmablasts

Multiple sclerosis and related disorders, 2020-06, Vol.41, p.102005-102005, Article 102005

2020

Volltextzugriff (PDF)

Health-related quality of life in Japanese patients with multiple sclerosis

Journal of neurology, 2023-02, Vol.270 (2), p.1011-1018

2023

Volltextzugriff (PDF)

Tacrolimus is effective for neuromyelitis optica spectrum disorders with or without anti-AQP4 antibody

Multiple sclerosis and related disorders, 2020-04, Vol.39, p.101907-101907, Article 101907

2020

Volltextzugriff (PDF)

Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration

Multiple sclerosis and related disorders, 2022-04, Vol.60, p.103730-103730, Article 103730

2022

Volltextzugriff (PDF)

Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica

Multiple sclerosis, 2016-09, Vol.22 (10), p.1337-1348

2016

Volltextzugriff (PDF)

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

Nature medicine, 2007-02, Vol.13 (2), p.211-217

2007

Volltextzugriff (PDF)

Myelin oligodendrocyte glycoprotein (MOG) antibody and demyelination

Nihon rinshō, 2010-06, Vol.68 Suppl 6, p.637

Fukaura, Hikoaki

2010

Volltextzugriff (PDF)

Immunological Analysis of MOG autoantibody positive NMOSD and aquaporin-4 autoantibody positive NMOSD (P5.252)

Neurology, 2015-04, Vol.84 (14_supplement)

2015

Volltextzugriff (PDF)

How do we cure the medical divide between northern Tohoku district and Tokyo?

Rinsho Shinkeigaku, 2010, Vol.50(11), pp.1069-1072

Fukaura, Hikoaki

2010

Volltextzugriff (PDF)

Anti-myelin oligodendrocyte glycoprotein antibody-positive neurologic disease, manifested as clinical course of classical Devic’s disease: A case report

Rinshō shinkeigaku, 2020, Vol.60 (3), p.219-222

2020

Volltextzugriff (PDF)

Comparison of Plasma Exchange, Methylprednisolone Pulse Therapy and Intravenous Immunoglobulin in Oxidative Stress (P01.190)

Neurology, 2013-02, Vol.80 (7_supplement)

2013

Volltextzugriff (PDF)

Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis

BMC neurology, 2014-01, Vol.14 (1), p.3-3, Article 3

2014

Volltextzugriff (PDF)

Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan

Multiple sclerosis and related disorders, 2024-10, Vol.90, p.105829, Article 105829

2024

Volltextzugriff (PDF)

Manpower in neurological care in rural and urban Japan

Rinsho shinkeigaku = Clinical neurology, 2010-11, Vol.50 (11), p.1058

Fukaura, Hikoaki

2010

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(53)

Sprache

Englisch
(44)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data

Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan

Association between peripheral plasmablasts and postoperative exacerbation in patients with thymoma‐associated myasthenia gravis

Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial

Cognition with magnetic resonance imaging findings and social activities in patients with multiple sclerosis in a Japanese cohort

Diagnostic criteria to patients with multiple sclerosis and clinically isolated syndrome

Disease modifying therapies in multiple sclerosis

Detection of Active Plaques in Multiple Sclerosis using Susceptibility-weighted Imaging: Comparison with Gadolinium-enhanced MR Imaging

Association of cognitive impairment with magnetic resonance imaging findings and social activities in patients with multiple sclerosis

Ibudilast, a nonselective phosphodiesterase inhibitor, regulates Th1/Th2 balance and NKT cell subset in multiple sclerosis

Present status of Japanese neurologists from the questionnaire survey - to support women doctor's career advancement

Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood–brain barrier breakdown and peripheral plasmablasts

Health-related quality of life in Japanese patients with multiple sclerosis

Tacrolimus is effective for neuromyelitis optica spectrum disorders with or without anti-AQP4 antibody

Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration

Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

Myelin oligodendrocyte glycoprotein (MOG) antibody and demyelination

Immunological Analysis of MOG autoantibody positive NMOSD and aquaporin-4 autoantibody positive NMOSD (P5.252)

How do we cure the medical divide between northern Tohoku district and Tokyo?

Anti-myelin oligodendrocyte glycoprotein antibody-positive neurologic disease, manifested as clinical course of classical Devic’s disease: A case report

Comparison of Plasma Exchange, Methylprednisolone Pulse Therapy and Intravenous Immunoglobulin in Oxidative Stress (P01.190)

Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis

Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan

Manpower in neurological care in rural and urban Japan

Suchergebnisse filtern